1304017-12-6

Basic information

• Product Name: (E)-N'-((6-(1H-indol-2-yl)imidazo[1,2-a]pyridin-3-yl)methylene)-5-fluoro-N,2-dimethylbenzenesulfonohydrazide
• Synonyms: (E)-N'-((6-(1H-indol-2-yl)imidazo[1,2-a]pyridin-3-yl)methylene)-5-fluoro-N,2-dimethylbenzenesulfonohydrazide
• CAS NO: 1304017-12-6
• Molecular Weight: 461.52
• Mol File: 1304017-12-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (E)-N'-((6-(1H-indol-2-yl)imidazo[1,2-a]pyridin-3-yl)methylene)-5-fluoro-N,2-dimethylbenzenesulfonohydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-N'-((6-(1H-indol-2-yl)imidazo[1,2-a]pyridin-3-yl)methylene)-5-fluoro-N,2-dimethylbenzenesulfonohydrazide(1304017-12-6)
• EPA Substance Registry System: (E)-N'-((6-(1H-indol-2-yl)imidazo[1,2-a]pyridin-3-yl)methylene)-5-fluoro-N,2-dimethylbenzenesulfonohydrazide(1304017-12-6)

Safety Data

• Hazardous Substances Data: 1304017-12-6(Hazardous Substances Data)

Upstream product

• 1304017-56-8 tert-butyl 2-(3-formylimidazo[1,2-a]pyridin-6-yl)-1H-indole-1-carboxylate 
• 30384-96-4 6-bromoimidazo[1,2-a]pyridine-3-carbaldehyde 
• 445-05-6 5-fluoro-2-methylbenzenesulfonyl chloride 
• 1072-97-5 5-bromo-2-pyridylamine 

Relevant articles and documents

IMIDAZOPYRIDINE DERIVATIVES

The present invention relates to compounds of formula (I), wherein Ra, Rb, Rc, Rd, Re and Rf are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases mediated by phosphatidylinositol-3-kinase (PBK), mammalian target of rapamycin (mTOR), Signal transducer and activator of transcription 3 (STAT 3), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) or a combination thereof particularly in the treatment of cancer and inflammation.